Evaluation of treatment with natalizumab therapy on triple risk patients regarding progressive multifocal leukoencephalopathy

Authors
Category Primary study
JournalEuropean Journal of Hospital Pharmacy
Year 2016
This article has no abstract
Epistemonikos ID: a31476eed9bba6bce0eef1eae4ea25331e3a2767
First added on: Feb 08, 2025